Herbalife Ltd (NYSE:HLF) Receives $17.75 Average PT from Brokerages

Herbalife Ltd (NYSE:HLF) has been assigned an average rating of “Moderate Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $17.75.

A number of equities research analysts recently weighed in on the company. Maxim Group assumed coverage on Herbalife in a research note on Tuesday, January 6th. They issued a “buy” rating and a $20.00 price target on the stock. Zacks Research raised shares of Herbalife from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 19th. Citigroup reissued a “buy” rating and issued a $21.00 price objective (up from $17.00) on shares of Herbalife in a research report on Thursday, February 19th. Weiss Ratings restated a “hold (c)” rating on shares of Herbalife in a research note on Thursday, January 22nd. Finally, Mizuho lifted their target price on shares of Herbalife from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Monday.

Institutional Investors Weigh In On Herbalife

Institutional investors have recently made changes to their positions in the company. Fund 1 Investments LLC acquired a new position in Herbalife in the 2nd quarter valued at $8,491,000. Manatuck Hill Partners LLC boosted its position in shares of Herbalife by 122.2% in the third quarter. Manatuck Hill Partners LLC now owns 1,000,000 shares of the company’s stock valued at $8,440,000 after acquiring an additional 550,000 shares during the period. Invenomic Capital Management LP bought a new stake in shares of Herbalife in the third quarter valued at about $3,550,000. Johnson Financial Group LLC grew its stake in shares of Herbalife by 1,156.1% in the fourth quarter. Johnson Financial Group LLC now owns 414,500 shares of the company’s stock valued at $5,343,000 after acquiring an additional 381,500 shares in the last quarter. Finally, Invesco Ltd. grew its stake in shares of Herbalife by 60.5% in the third quarter. Invesco Ltd. now owns 763,857 shares of the company’s stock valued at $6,447,000 after acquiring an additional 287,880 shares in the last quarter.

Herbalife Trading Down 3.6%

NYSE HLF opened at $13.87 on Tuesday. Herbalife has a 12 month low of $6.20 and a 12 month high of $20.40. The stock has a 50 day moving average of $16.50 and a 200-day moving average of $13.08. The company has a market cap of $1.43 billion, a PE ratio of 6.30, a PEG ratio of 0.86 and a beta of 0.95.

Herbalife (NYSE:HLF) last issued its earnings results on Thursday, February 19th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.03). The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.24 billion. Herbalife had a negative return on equity of 35.02% and a net margin of 4.53%.Herbalife’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.36 earnings per share. As a group, sell-side analysts predict that Herbalife will post 1.57 EPS for the current fiscal year.

About Herbalife

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.